Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Livzon Biologics is a biopharmaceutical company based in Zhuhai, China, specializing in the development, manufacturing, and commercialization of innovative biologics and biosimilars. As a subsidiary of Livzon Pharmaceutical Group, the company focuses on high-growth therapeutic areas including oncology, immunology, and infectious diseases. Their portfolio includes a mix of self-developed novel antibodies and high-quality biosimilars, supported by large-scale GMP manufacturing capabilities. Livzon Biologics gained significant prominence for its recombinant protein COVID-19 vaccine and its robust pipeline of PD-1 and HER2 targeted therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhuhai Lizhu Biopharmaceutical.